HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.

Abstract
Membrane-associated prostaglandin (PG) E(2) synthase-1 (mPGES-1) catalyzes the conversion of PGH(2) to PGE(2), which contributes to many biological processes. Peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-activated transcription factor and plays an important role in growth, differentiation, and inflammation in different tissues. Here, we examined the effect of PPARgamma ligands on interleukin-1beta (IL-1beta)-induced mPGES-1 expression in human synovial fibroblasts. PPARgamma ligands 15-deoxy-Delta(12,14) prostaglandin J(2) (15d-PGJ(2)) and the thiazolidinedione troglitazone (TRO), but not PPARalpha ligand Wy14643, dose-dependently suppressed IL-1beta-induced PGE(2) production, as well as mPGES-1 protein and mRNA expression. 15d-PGJ(2) and TRO suppressed IL-1beta-induced activation of the mPGES-1 promoter. Overexpression of wild-type PPARgamma further enhanced, whereas overexpression of a dominant negative PPARgamma alleviated, the suppressive effect of both PPARgamma ligands. Furthermore, pretreatment with an antagonist of PPARgamma, GW9662, relieves the suppressive effect of PPARgamma ligands on mPGES-1 protein expression, suggesting that the inhibition of mPGES-1 expression is mediated by PPARgamma. We demonstrated that PPARgamma ligands suppressed Egr-1-mediated induction of the activities of the mPGES-1 promoter and of a synthetic reporter construct containing three tandem repeats of an Egr-1 binding site. The suppressive effect of PPARgamma ligands was enhanced in the presence of a PPARgamma expression plasmid. Electrophoretic mobility shift and supershift assays for Egr-1 binding sites in the mPGES-1 promoter showed that both 15d-PGJ(2) and TRO suppressed IL-1beta-induced DNA-binding activity of Egr-1. These data define mPGES-1 and Egr-1 as novel targets of PPARgamma and suggest that inhibition of mPGES-1 gene transcription may be one of the mechanisms by which PPARgamma regulates inflammatory responses.
AuthorsSaranette Cheng, Hassan Afif, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Xinfang Li, Katherine Farrajota, Martin Lavigne, Hassan Fahmi
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 279 Issue 21 Pg. 22057-65 (May 21 2004) ISSN: 0021-9258 [Print] United States
PMID15023995 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 15-deoxy-delta(12,14)-prostaglandin J2
  • 2-chloro-5-nitrobenzanilide
  • Anilides
  • Chromans
  • DNA, Complementary
  • DNA-Binding Proteins
  • EGR1 protein, human
  • Early Growth Response Protein 1
  • Immediate-Early Proteins
  • Immunologic Factors
  • Interleukin-1
  • Ligands
  • Peroxisome Proliferators
  • Pyrimidines
  • Receptors, Cytoplasmic and Nuclear
  • Thiazolidinediones
  • Transcription Factors
  • RNA
  • pirinixic acid
  • Intramolecular Oxidoreductases
  • PTGES protein, human
  • Prostaglandin-E Synthases
  • Troglitazone
  • Prostaglandin D2
Topics
  • Amino Acid Motifs
  • Anilides (pharmacology)
  • Binding Sites
  • Blotting, Western
  • Cell Division
  • Cell Nucleus (metabolism)
  • Chromans (pharmacology)
  • DNA, Complementary (metabolism)
  • DNA-Binding Proteins (metabolism)
  • Dose-Response Relationship, Drug
  • Early Growth Response Protein 1
  • Fibroblasts (metabolism)
  • Genes, Dominant
  • Genes, Reporter
  • Humans
  • Immediate-Early Proteins (metabolism)
  • Immunologic Factors (pharmacology)
  • Inflammation
  • Interleukin-1 (metabolism)
  • Intramolecular Oxidoreductases (biosynthesis)
  • Ligands
  • Peroxisome Proliferators (pharmacology)
  • Plasmids (metabolism)
  • Promoter Regions, Genetic
  • Prostaglandin D2 (analogs & derivatives, metabolism)
  • Prostaglandin-E Synthases
  • Protein Binding
  • Pyrimidines (pharmacology)
  • RNA (metabolism)
  • Receptors, Cytoplasmic and Nuclear (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Synovial Membrane (cytology)
  • Thiazolidinediones (pharmacology)
  • Time Factors
  • Transcription Factors (metabolism)
  • Transcription, Genetic
  • Transfection
  • Troglitazone

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: